Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.2B | 4.0B | 3.7B | 3.6B |
Cost of revenue | 2.1B | 1.8B | 1.6B | 1.6B |
Gross profit | 2.2B | 2.2B | 2.1B | 2.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 187M | 182M | 176M | 179M |
Other operating expenses | — | -81M | -1M | -1M |
Operating income | 1.1B | 1.2B | 1.0B | 993M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 235M | 149M | 214M | 241M |
Pretax income | 929M | 891M | 764M | 770M |
Tax provision | 186M | 197M | 113M | 168M |
Net income | 743M | 694M | 651M | 602M |
Basic EPS | 0.3 | 0.3 | 0.3 | 0.3 |
Diluted EPS | 0.3 | 0.3 | 0.3 | 0.3 |
Basic average shares | 2.2B | 2.2B | 2.2B | 2.2B |
Diluted average shares | 2.2B | 2.2B | 2.2B | 2.2B |
EBITDA | 1.8B | 1.8B | 1.6B | 1.5B |
Net income from continuing op. | 743M | 694M | 651M | 602M |
Minority interests | -26M | -27M | -26M | -27M |
Preferred stock dividends | 4M | 4M | 4M | 3M |